Self-funded plans have been wrestling with GLP-1s long before this lawsuit
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I
Without a healthcare provider to guide the process, people often take incorrect doses or skip the necessary gradual titration, which can result in severe gastrointestinal issues and, in some cases, hospitalizations
Were looking for subtle changes So a patient who started out say six months ago and he was zero point eight and today hes at one point four, theyre both considered normal
Lee C et al
It is recommended that patients taking Trulicity or another GLP-1 agonist, weigh the benefits of using the medication against the potential risks, particularly when using the drug for a non-diabetic condition such as weight loss